EP 1322645 A2 20030702 - QUINAZOLINES, MEDICAMENTS, WHICH CONTAIN THESE COMPOUNDS AND WHICH ARE EFFECTIVE AS TYROSINE KINASE INHIBITORS, THEIR USE, AND METHODS FOR THE PRODUCTION THEREOF
Title (en)
QUINAZOLINES, MEDICAMENTS, WHICH CONTAIN THESE COMPOUNDS AND WHICH ARE EFFECTIVE AS TYROSINE KINASE INHIBITORS, THEIR USE, AND METHODS FOR THE PRODUCTION THEREOF
Title (de)
CHINAZOLINE, DIESE VERBINDUNGEN ENTHALTENDE ALS TYROSINKINASE INHIBITOREN WIRKSAME ARZNEIMITTEL, DEREN VERWENDUNG UND VERFAHREN ZU IHRER HERSTELLUNG
Title (fr)
QUINAZOLINES, MEDICAMENTS A EFFET INHIBANT LA TYROSINE-KINASE ET CONTENANT LESDITS COMPOSES, LEUR UTILISATION ET PROCEDES PERMETTANT DE LES PRODUIRE
Publication
Application
Priority
- DE 10042064 A 20000826
- EP 0109534 W 20010818
Abstract (en)
[origin: WO0218375A1] The invention relates to quinazolines of general formula (I), in which Ra, Rb and n are defined as referred to in Claim No. 1, to their tautomers, their stereoisomers, and to their salts, particularly their physiologically compatible salts with inorganic or organic acids or bases, which have valuable pharmacological properties, in particular, an inhibitive effect on the signal transduction imparted by tyrosine kinases. The invention also relates to the use of said quinazolines for treating diseases, especially tumor diseases, disorders of the lung and of the respiratory tract, and to the production thereof.
IPC 1-7
IPC 8 full level
A61K 31/505 (2006.01); A61K 31/517 (2006.01); A61K 31/5377 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01); A61P 1/16 (2006.01); A61P 7/00 (2006.01); A61P 11/00 (2006.01); A61P 11/02 (2006.01); A61P 11/06 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 35/00 (2006.01); C07D 239/94 (2006.01); C07D 405/12 (2006.01); C07D 413/12 (2006.01)
CPC (source: EP)
A61K 31/505 (2013.01); A61P 1/00 (2017.12); A61P 1/04 (2017.12); A61P 1/16 (2017.12); A61P 7/00 (2017.12); A61P 11/00 (2017.12); A61P 11/02 (2017.12); A61P 11/06 (2017.12); A61P 13/12 (2017.12); A61P 17/00 (2017.12); A61P 35/00 (2017.12); C07D 239/94 (2013.01); C07D 405/12 (2013.01); C07D 413/12 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0218375 A1 20020307; AU 1044402 A 20020313; CA 2417955 A1 20030130; DE 10042064 A1 20020307; EP 1322645 A2 20030702; JP 2004507537 A 20040311; MX PA03001484 A 20030606
DOCDB simple family (application)
EP 0109534 W 20010818; AU 1044402 A 20010818; CA 2417955 A 20010818; DE 10042064 A 20000826; EP 01978279 A 20010818; JP 2002523890 A 20010818; MX PA03001484 A 20010818